Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease - Test2 - elhamkhani - TriplyDB

Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q24202510

about

Combined aclidinium bromide and long-acting beta 2 -agonist for COPD Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk Effect of salmeterol/fluticasone combination on the dynamic changes of lung mechanics in mechanically ventilated COPD patients: a prospective pilot study.The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon.Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis.Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome.The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials.Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease.Coping with complexity: working beyond the guidelines for patients with multimorbidities.Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects.A randomized trial of symptom-based management in Japanese patients with COPD Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy

P2860

Q24187613-619C0263-84AF-474E-8A34-4C80799F47A6 Q24197989-46EB7D4C-A81B-4610-B69B-A97B513BDCED Q26471530-2E4F4CA3-1CFA-4B7C-831B-619509FB4E9F Q26778794-9FA456EC-2178-4516-8A9A-A9513E95353E Q26786229-A5CDEE95-2CF8-4C66-833E-12325C1C9AA2 Q26801661-D6B2301C-AFE6-49DA-83B0-FC78C0961178 Q28070274-3E273DD4-3BBE-45B3-A740-BB4DF5A8D047 Q30238494-4294C3B5-A246-4B58-8A09-F8ADEC3F7936 Q33646667-3D5CA3FC-0829-4520-8147-35CEDDF4C371 Q35538249-37F4911F-BA92-4EB6-9246-CD96D377C308 Q35595077-D1A037A3-734E-4749-A36E-59974FFE816B Q36116549-760565B2-C0F2-4E6E-B9DA-D450B7376FD7 Q36412770-620D6B70-4830-4DE8-8361-27C8B80DF09A Q36525631-9C16185E-7E3E-4518-9AB3-70B6591D3E17 Q37456602-05848C88-8875-4FD3-B21C-1C619B1146B8 Q37614090-28170CB6-C5C7-4739-A016-7FEA37A3D062 Q37741110-D3A51A63-552B-4100-BE76-0935D08A4AFC Q38215747-48ADD382-CD88-4C6C-BC0F-D555C2393D3F Q38681962-1B727980-BC6C-45A6-8F0F-D860898BB489 Q40706819-234EDBB4-0C8E-4568-994B-A986C702D612 Q42364461-163AED19-5800-43DD-8BDF-C621035E5F3E Q47096485-D24C28DC-3630-4A86-988E-2C5FCC9CA0CF Q47964378-7A9EFD2F-633D-477D-AE39-054AC3B7AD3A Q55221198-B0522AC7-1F19-41AD-A160-E55D325AE980 Q55335157-DF96F7A6-922F-4A4D-B3EA-36C044A8C3BF Q58785953-B21562C4-EAA5-4555-BFBD-FA87A1A23209 Q59127184-6923940A-1145-435F-A637-5A4131113302

P2860

Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

http://www.wikidata.org/entity/Q24202510

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Combined corticosteroid and lo ...... obstructive pulmonary disease

@ast

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en-gb

Combined corticosteroid and lo ...... obstructive pulmonary disease

@nl

type

label

Combined corticosteroid and lo ...... obstructive pulmonary disease

@ast

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en-gb

Combined corticosteroid and lo ...... obstructive pulmonary disease

@nl

altLabel

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en

prefLabel

Combined corticosteroid and lo ...... obstructive pulmonary disease

@ast

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en-gb

Combined corticosteroid and lo ...... obstructive pulmonary disease

@nl

P1433

Q24202510-25B0B181-29E1-433B-AE0E-094FD95566E3

P1476

Q24202510-3F5C56DD-AEB9-4E03-82FF-668C3631B77B

P2093

Q24202510-266DD8AD-EA5C-454F-9781-F8C4A38C37FE

Q24202510-4E508660-9DF3-486F-8C5D-D40F9461C33F

Q24202510-9EC56427-DD4E-4883-869A-B777AEE75981

Q24202510-B33494C6-71A8-42C5-A463-2C7ACC55FAD2

Q24202510-E21CC62A-84F9-4670-BBF4-526E846DEBA7

P2860

Q24202510-03679552-DA6E-4F72-B933-8F22E7A3D239

Q24202510-084D92FF-729E-40E7-BDA8-BF775B483B94

Q24202510-091C51AD-AF8F-48F2-A51C-3B26217A7CEB

Q24202510-0938E152-81A4-46EC-BE90-D9489E9C7576

Q24202510-0CF9545F-3180-4FA5-B164-A4D9CA3D9E6A

Q24202510-0ED67374-03A6-4C1B-8CA0-C9CF3C257718

Q24202510-142F54AD-65EE-49B5-A01E-758CEA3D94C6

Q24202510-1AC9B39C-16F8-425A-B1BA-0CEB9EEF174D

Q24202510-1BAB34EA-D036-4B29-8FC6-CBF5F62E241D

Q24202510-1D2E8B1F-E736-46AF-AF69-011EABE543A5

P304

Q24202510-8F4ED231-7E1F-4450-83F3-3637FF855952

P31

Q24202510-38531A72-4E1D-4D75-B21E-3CAFDE3551B1

Q24202510-a172fd60-1ea4-4ccd-b2d5-d1e8b578c4ec

P3181

Q24202510-775D35E0-274A-467A-BF7D-57E4FBF01B9C

P356

Q24202510-FE078985-1932-4EC3-93EF-F64829015DD7

P407

Q24202510-80890139-CC81-49FB-A97C-F3BF56F7F8D8

P433

Q24202510-7D4FD60D-4B7C-40C3-82FF-B4E17662ACA4

P50

Q24202510-F1E2C2BB-C1D1-462D-94FE-4F1FD5E9DEFD

P577

Q24202510-4440968A-A6B5-4A4D-B95D-5347A7F7DB4F

P698

Q24202510-A027C374-9080-4744-BEFD-8FD376C468C8

P921

Q24202510-914C0EB3-7C21-44BC-B1F5-D918F200F930

Q24202510-E2B8E9AE-DE07-46B9-BCE2-807A14232FE0

P932

Q24202510-E171DA95-AA74-4E17-9322-F79379EEA6F5

P3181

P356

14651858.CD003794.PUB4

P1433

Cochrane Database of Systematic Reviews

P1476

Combined corticosteroid and lo ...... obstructive pulmonary disease

@en

P2093

Luis Javier Nannini

http://www.w3.org/2001/XMLSchema#string

Phillippa Poole

http://www.w3.org/2001/XMLSchema#string

Rebecca Holmes

http://www.w3.org/2001/XMLSchema#string

Rebecca Normansell

http://www.w3.org/2001/XMLSchema#string

Stephen J Milan

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children

Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children

Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease

P304

CD003794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2275721

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD003794.PUB4

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P50

Phillippa Poole

P577

2013-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24214176

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

6485527

http://www.w3.org/2001/XMLSchema#string